
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
A study in Antioxidants & Redox Signaling provides a bit more evidence suggesting that using mobile phones or cell phones in the U.S. can boost the risk of brain cancer.
by Jimmy Downs
As bicycle riding becomes an increasingly popular sport in Israel, there is an increasing danger of accidents and injuries.
A new advanced technology has been developed for the first time worldwide, at Rabin Medical Center's Invasive Cardiology Institute, where all pertinent information collected during the cardiac catheterization procedure is sent directly to an iPad.